Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Browse all Peptides and GLP-1 education Retatrutide cost is one of the most-searched questions in the GLP-1 and incretin-pathway landscape as of May 2026
5 Novo Nordisk also referenced cardiovascular benefit data for the molecule in adults, 1 but those findings should not be extrapolated to pediatric patients without direct evidence
revenues with LOE in 2028-2029 and assuming 80 percent revenue erosion over three years post-LOE, the NPV of the formulation patent protection from 2026 to 2028 (the period beyond the compound patent expiry) is approximately $16 billion to $20 billion at a 10 percent discount rate
Findings suggest Tirzepatide could be a promising option for sustainable weight management
US$ 21.91
US$ 26.22
US$ 21.33
US$ 28.98
